FIELD: chemistry.
SUBSTANCE: present invention relates to the compound of Formula I, in which R1 represents C1-8 alkyl, C1-8 alkoxy, CN, COOCH3 or halogen, and R2 represents H, C1-8 alkyl, Bn-. Invention also relates to the pharmaceutical composition, to the compound of Formula I preparation method, to the human or animal body treatment method. 
Formula I.
EFFECT: technical result: new compounds of Formula I have been produced, which possess the CB1 receptor inhibitor properties, can be used in the human or animal treatment suffering from the associated with CB-1 pathology.
10 cl, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| CB1 RECEPTOR ANTAGONISTS | 2012 |
|
RU2593751C2 |
| DERIVATIVES OF CINNAMIC ACID AMIDE | 2003 |
|
RU2318802C2 |
| 3β-(Benzyloxy)-17α-METHYL-PREGN-5-EN-20-ONE FOR USE IN THE TREATMENT OF COGNITIVE DISORDERS | 2019 |
|
RU2796005C2 |
| CYANOQUINOLINE DERIVATIVES | 2011 |
|
RU2600928C2 |
| SUBSTITUTED PIPERIDINES AS NEW MDM2-p53 INHIBITORS | 2004 |
|
RU2333201C2 |
| NEW ESTERS OF HYDROXIMIC ACIDS AND THEIR PHARMACEUTICAL APPLICATION | 2004 |
|
RU2357952C2 |
| PYRROLO[3,2-b]PYRIDINE DERIVATIVES AND METHOD OF PRODUCING SAID DERIVATIVES | 2005 |
|
RU2397170C2 |
| PYRROLIDONE DERIVATIVES AS MAO INHIBITORS | 2003 |
|
RU2336267C2 |
| ALPHA-AMINOAMIDE DERIVATIVES USED FOR TREATING LOWER URINARY TRACT DISORDERS | 2005 |
|
RU2395504C2 |
| PHTHALIMIDO-DERIVATIVES AS MONOAMINE OXIDASE B INHIBITORS | 2003 |
|
RU2317289C2 |
